Skip to main content

Company News

  • March 19, 2024

    bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens

    bioMérieux has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens.
    Read more

  • January 18, 2024

    bioMérieux and the University of Pittsburgh Form Research Partnership

    A strategic R&D partnership between bioMérieux and the University of Pittsburgh (Pitt) has been launched, paving the way for many innovative and collaborative research projects.
    Read more

  • December 18, 2023

    CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies

    CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries).
    Read more

  • December 13, 2023

    bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America

    In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology.
    Read more

  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
    Read more